Endo Sells International Pharmaceuticals Business to Knight Therapeutics for $105 MillionBusiness PenJune 17, 2025June 18, 2025 June 17, 2025June 18, 2025 Endo, Inc. (OTCQX: NDOI) has wrapped up the sale of its International Pharmaceuticals business, marking a significant shift in the company’s focus and portfolio. The...
